Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.5T | 14.8T | 16.3T | 15.2T |
Cost of revenue | 9.2T | 8.8T | 9.4T | 9.0T |
Gross profit | 6.3T | 6.1T | 6.9T | 6.2T |
Operating expense | ||||
Research & development | 504.2B | 489.9B | 535.8B | 495.6B |
Selling general and admin | 3.1T | 3.0T | 3.2T | 3.0T |
Other operating expenses | — | — | — | — |
Operating income | 2.7T | 2.6T | 3.2T | 2.7T |
Non operating interest income | ||||
Income | 425.5B | 290.8B | 325.2B | 396.8B |
Expense | 578.7B | 434.0B | 454.1B | 510.0B |
Other income expense | -144.7B | -136.1B | -306.6B | -87.4B |
Pretax income | 2.4T | 2.3T | 2.8T | 2.5T |
Tax provision | 131.8B | 136.1B | 214.9B | 141.8B |
Net income | 2.3T | 2.2T | 2.6T | 2.3T |
Basic EPS | 4.3 | 4.0 | 4.8 | 4.3 |
Diluted EPS | 4.3 | 4.0 | 4.8 | 4.3 |
Basic average shares | 541.5B | 541.5B | 547.2B | 547.2B |
Diluted average shares | 541.5B | 542.9B | 548.6B | 550.1B |
EBITDA | 4.1T | 3.9T | 4.6T | 4.1T |
Net income from continuing op. | 2.3T | 2.2T | 2.6T | 2.3T |
Minority interests | -2.9B | -5.7B | 8.6B | 0 |
Preferred stock dividends | — | — | — | — |